Streetbeat News

Analyst Ratings

DFS

BMO Capital analyst James Fotheringham maintains a 'Market Perform' rating on Discover Financial Services (NYSE:DFS) but has lowered the price target from $103 to $99.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:57 am

KNX

Susquehanna analyst Bascome Majors has maintained a Neutral rating on Knight-Swift (NYSE:KNX) and lowered the price target from $53 to $51.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:56 am

SLB

SLB (NYSE:SLB) reported Q2 earnings of $0.72 per share, beating the analyst consensus estimate of $0.71 by 1.41%. However, the company's quarterly sales of $8.10 billion missed the analyst consensus estimate of $8.22 billion by 1.47%. This represents a 44% increase in earnings and a 19.58% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:54 am

PFE

Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Pfizer (NYSE:PFE) and lowered the price target from $43 to $42.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:54 am

LLY

Morgan Stanley analyst David Phung has maintained an Overweight rating on Eli Lilly (NYSE:LLY) and raised the price target from $551 to $560.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:53 am

LFMD

Cantor Fitzgerald analyst Sarah James has initiated coverage on LifeMD (NASDAQ:LFMD) with an Overweight rating and a price target of $7.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 10:53 am

CSX

BMO Capital analyst Fadi Chamoun has reiterated an Outperform rating on CSX (NASDAQ:CSX) and maintained a $37 price target.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:52 am

MMC

Wells Fargo analyst Elyse Greenspan maintains an Overweight rating on Marsh & McLennan (NYSE:MMC) and raises the price target from $200 to $208.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 10:51 am

ALV

Autoliv Inc reported Q2 FY23 sales growth of 27% YoY to $2.63 billion, beating the analyst consensus. Adjusted operating income increased 71% to $212 million. The company announced a cost reduction plan expected to save around $75 million when fully completed. Adjusted EPS of $1.93 beat the analyst consensus. Autoliv continues to see FY23 organic sales growth of around 15%, adjusted operating margin of around 8.5%-9%, and $900 million in operating cash flow.

Portfolio Pulse from Shivani Kumaresan

July 21, 2023 | 10:51 am

ARWR

TD Cowen analyst Brendan Smith has initiated coverage on Arrowhead Pharma (NASDAQ:ARWR) with an Outperform rating.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 10:50 am